Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122247
Filing Date
2024-11-06
Accepted
2024-11-06 16:02:23
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sldb-20240930.htm   iXBRL 10-Q 2444717
2 EX-31.1 sldb-ex31_1.htm EX-31.1 15408
3 EX-31.2 sldb-ex31_2.htm EX-31.2 15379
4 EX-32.1 sldb-ex32_1.htm EX-32.1 8847
5 EX-32.2 sldb-ex32_2.htm EX-32.2 8830
6 GRAPHIC img246675356_0.jpg GRAPHIC 546444
  Complete submission text file 0000950170-24-122247.txt   9453268

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sldb-20240930.xsd EX-101.SCH 1295496
66 EXTRACTED XBRL INSTANCE DOCUMENT sldb-20240930_htm.xml XML 1205735
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 241430802
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)